Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Esmay Frankin"'
Autor:
Els Verdegaal, Hergen Spits, Remko Schotte, Martijn Kedde, Gemma Moiset, Hans Van Eenennaam, Pauline van Helden, Sjoerd van der Burg, Julien Villaudy, Wouter Pos, Daniel Go, Christien Fatmawati, Etsuko Yasuda, Madalina Cercel, Esmay Frankin, Susan van Hal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/db80a70a00dd4578b39f1f849964e0ec
Autor:
Otávio de Melo Espíndola, Esther Siteur-van Rijnstra, Esmay Frankin, Kees Weijer, Yme Ubeles van der Velden, Ben Berkhout, Bianca Blom, Julien Villaudy
Publikováno v:
Cells, Vol 10, Iss 10, p 2514 (2021)
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy of CD4+ T-cells associated with HTLV-1 infection. In this study, we used the model of immunodeficient NSG mice reconstituted with a functional human immune system (HIS) to investigate
Externí odkaz:
https://doaj.org/article/1ed3b594db9c4b3a8ace1167fd2d9719
Autor:
Kees Weijer, Esmay Frankin, Bianca Blom, Ben Berkhout, Julien Villaudy, Otávio de Melo Espíndola, Esther Siteur-van Rijnstra, Yme U. van der Velden
Publikováno v:
Cells, Vol 10, Iss 2514, p 2514 (2021)
Cells, 10(10):2514. MDPI Multidisciplinary Digital Publishing Institute
Cells
Volume 10
Issue 10
Cells, 10(10):2514. MDPI Multidisciplinary Digital Publishing Institute
Cells
Volume 10
Issue 10
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy of CD4+ T-cells associated with HTLV-1 infection. In this study, we used the model of immunodeficient NSG mice reconstituted with a functional human immune system (HIS) to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2970c387d2074d9183f78670cf385963
https://www.mdpi.com/2073-4409/10/10/2514
https://www.mdpi.com/2073-4409/10/10/2514
Autor:
Susan van Hal, Pauline M. van Helden, Els M. E. Verdegaal, Daniel Go, Martijn Kedde, Madalina Cercel, Hans van Eenennaam, Esmay Frankin, Etsuko Yasuda, Hergen Spits, Christien Fatmawati, Julien Villaudy, Sjoerd H. van der Burg, Wouter Pos, Gemma Moiset, Remko Schotte
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Adaptive immunity to cancer cells forms a crucial part of cancer immunotherapy. Recently, the importance of tumor B-cell signatures were shown to correlate with melanoma survival. We investigated whether tumor-targeting antibodies could be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbd04cbbc66a80ff7b13b96463d3ca9
https://doi.org/10.1136/jitc-2020-sitc2020.0721
https://doi.org/10.1136/jitc-2020-sitc2020.0721
Autor:
Anikó Szabó, Sjeng Horbach, Remko Schotte, Susan E. van Hal-van Veen, Madalina Cercel, Hans van Eenennaam, Anita W. Rijneveld, Dorien van de Berg, Mette D. Hazenberg, Wouter Pos, Yvonne Claassen, Etsuko Yasuda, Hergen Spits, Piet Gros, Christien Fatmawati, Julien Villaudy, Esmay Frankin, Greta de Jong, Sophie E. Levie, Daniel M Go, Martijn Kedde, Viviana Neviani
Publikováno v:
Blood. 136:41-42
Despite recent advances in treatment of B-acute lymphoblastic leukemia (B-ALL) there is still a need for novel targeted therapies. The tetraspanin CD9 is expressed in 60-80% of B-ALL and correlates with adverse prognosis. Recently, the mouse CD9 anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f64a67151140de54b55a6be48f6f3103
https://doi.org/10.1182/blood-2020-134088
https://doi.org/10.1182/blood-2020-134088
Autor:
Alex Harwig, Atze T. Das, Esmay Frankin, Yme U. van der Velden, Ben Berkhout, Esther Siteur-van Rijnstra, W Kleibeuker, Bep Klaver
Publikováno v:
Virology, 488, 96-107. Academic Press Inc.
Conditionally replicating HIV-1 variants that can be switched on and off at will are attractive tools for HIV research. We previously developed a genetically modified HIV-1 variant that replicates exclusively when doxycycline (dox) is administered. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52aa4f35d87b47f0ca73aaeae900e808
https://doi.org/10.1016/j.virol.2015.11.004
https://doi.org/10.1016/j.virol.2015.11.004
Autor:
Els M. E. Verdegaal, Remko Schotte, H. van Eenennaam, Madalina Cercel, Gemma Moiset, S.H. van der Burg, Wouter Pos, Christien Fatmawati, S. E. van Hal-van Veen, Etsuko Yasuda, Esmay Frankin, P. van Helden, Julien Villaudy, D. Go, Hergen Spits, Martijn Kedde, Koen Wagner
Publikováno v:
Annals of Oncology. 31:S492
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e71eb2f8245b6d7bb1717dba5b1c8e46
https://doi.org/10.1016/j.annonc.2020.08.694
https://doi.org/10.1016/j.annonc.2020.08.694
Autor:
Mette D. Hazenberg, Hergen Spits, Anikó Szabó, Greta de Jong, Remko Schotte, Madalina Cercel, Hans van Eenennaam, Martijn Kedde, Etsuko Yasuda, Pauline M. van Helden, Els M. E. Verdegaal, Sjoerd H. van der Burg, Wouter Pos, Sophie E. Levie, Esmay Frankin, Julien Villaudy, Daniel Go, Susan van Hal, Anita van Rijneveld
Publikováno v:
Cancer Research. 80:531-531
Introduction Despite rapid advances in immunotherapeutic options for precursor B-acute lymphoblastic leukemia (BCP-ALL), outcomes remain poor especially for adult ALL and relapsed pediatric ALL. With conventional chemotherapy remission percentages in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9213a45f34c6c731cdb6ee85edcdb2f0
https://doi.org/10.1158/1538-7445.am2020-531
https://doi.org/10.1158/1538-7445.am2020-531
Autor:
Kees Weijer, Yme U. van der Velden, Esther Siteur-van Rijnstra, Cynthia A. van der Linden, Edith E. Schermer, Esmay Frankin, Julien Villaudy, Monique Vink, Rogier W. Sanders, Ben Berkhout, Marit J. van Gils
Publikováno v:
AIDS research and human retroviruses, 34(9), 790-793. Mary Ann Liebert Inc.
Broadly neutralizing antibodies (bNAbs) such as PGDM1400 show promise as prophylactic and therapeutic agents against HIV-1. Human immune system mice were passively immunized with different doses of PGDM1400 and challenged 24 h later with a high dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1527357f2289efa7aee2c06eeebf3d
https://pure.amc.nl/en/publications/short-communication-protective-efficacy-of-broadly-neutralizing-antibody-pgdm1400-against-hiv1-challenge-in-humanized-mice(295c51b7-f99a-41a9-b8c1-3a698200d8a4).html
https://pure.amc.nl/en/publications/short-communication-protective-efficacy-of-broadly-neutralizing-antibody-pgdm1400-against-hiv1-challenge-in-humanized-mice(295c51b7-f99a-41a9-b8c1-3a698200d8a4).html
Autor:
Susan E. van Hal-van Veen, Remko Schotte, Anikó Szabó, Julien Villaudy, Anita W. Rijneveld, Pauline M. van Helden, Greta de Jong, Etsuko Yasuda, Madalina Cercel, Hans van Eenennaam, Mette D. Hazenberg, Daniel Go, Esmay Frankin, Wouter Pos, Hergen Spits, Sophie E. Levie
Publikováno v:
Blood. 134:4461-4461
Despite rapid advances in immunotherapeutic options for precursor B-acute lymphoblastic leukemia (ALL), outcomes remain poor especially for adult ALL and relapsed pediatric ALL. With conventional chemotherapy, remission percentages in adult ALL range
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a28ed814cb1b9c26912a1e4728fa2cd
https://doi.org/10.1182/blood-2019-127894
https://doi.org/10.1182/blood-2019-127894